Yunduan He

Microsatellite stable metastatic colorectal cancer without liver metastasis may be preferred population for regorafenib or fruquintinib plus sintilimab as third-line or above therapy:A real-world study

Caiyun Nie, Huifang Lv, Beibei Chen et al. · Frontiers in Oncology · 2022 · 22 citations · Full text

Medicine, Oncology, Pharmacology +13

Immune checkpoint inhibitors enhanced the antitumor efficacy of disitamab vedotin for patients with HER2-positive or HER2-low advanced or metastatic gastric cancer: a multicenter real-world study

Caiyun Nie, Weifeng Xu, Yanwei Guo et al. · BMC Cancer · 2023 · 18 citations · Full text

Medicine, Oncology, Pharmacology +17

Colonic electrical stimulation improves colonic transit in rotenone-induced Parkinson's disease model through affecting enteric neurons

Jin Bu, Xian Qiao, Yunduan He et al. · Life Sciences · 2019 · 17 citations

Life Sciences, Neurobiology, Neuroscience +17

Efficacy of regorafenib combined with PD-1 inhibitors in elderly patients with advanced metastatic colorectal cancer

Beibei Chen, Huichen Zhao, Jinxi Huang et al. · BMC Geriatrics · 2022 · 15 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer

Jianzheng Wang, Yunduan He, Baiwen Zhang et al. · Frontiers in Oncology · 2022 · 14 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17